HighMark Wealth Management LLC
13F holdings for Q2 2026 · ST. PAUL, MN · filed August 12, 2026
HighMark Wealth Management LLC reported $299M in 13F securities across 565 holdings for Q2 2026, in a Form 13F filed August 12, 2026. The largest positions were iShares TR (27.6%), Fidelity Covington Trust (6.6%), AXGN (5.3%). Reported value rose 21.5% from the quarter before. It opened 45 new positions, added to 155, trimmed 91 and sold out of 38.
- 13F value Q2 2026
- $299M
- Holdings
- 565
- Change vs prior quarter
- +21.5%
- Rank by 13F value
- #5,271
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Top holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| iShares TR | $82.3M | 27.6% | 109,892 | -6.0% | Trimmed |
| Fidelity Covington Trust | $19.7M | 6.6% | 254,403 | +3179938% | Added |
| AXGN Axogen Inc. | $15.8M | 5.3% | 341,390 | -1.0% | Trimmed |
| iShares TR | $15.3M | 5.1% | 51,019 | -6.6% | Trimmed |
| iShares Msci Eafe Value ETF | $15.2M | 5.1% | 199,183 | -9.6% | Trimmed |
| iShares Core S&P Small Cap ETF | $13.3M | 4.5% | 89,888 | -0.9% | Trimmed |
| Vanguard Index FDS | $10.7M | 3.6% | 15,529 | -5.9% | Trimmed |
| NEO NeoGenomics Inc. | $8.9M | 3.0% | 612,534 | +5.6% | Added |
| IUSV iShares Core S&P U.S. Value ETF | $8.3M | 2.8% | 75,506 | -6.2% | Trimmed |
| SIBN SI-BONE Inc. | $6.9M | 2.3% | 425,049 | +165.9% | Added |
| DWAS Invesco DWA SmallCap Momentum ETF | $5.9M | 2.0% | 46,538 | -0.7% | Trimmed |
| WFC Wells Fargo & Company | $5.7M | 1.9% | 68,644 | 0% | Unchanged |
| iShares Core S&P Mid-Cap ETF | $4.8M | 1.6% | 62,399 | +2.8% | Added |
| Apogee Therapeutics Inc Com | $4.3M | 1.4% | 32,266 | New | New |
| TWST Twist Bioscience Corporation | $4.0M | 1.3% | 39,030 | -0.7% | Trimmed |
| DUOT Duos Technologies Group Inc. | $3.5M | 1.2% | 289,884 | New | New |
| TLT iShares 20+ Year Treasury Bond ETF | $3.1M | 1.0% | 36,113 | +1.0% | Added |
| MASS 908 Devices Inc. | $3.0M | 1.0% | 339,783 | +6.4% | Added |
| ANAB AnaptysBio Inc. | $2.7M | 0.9% | 39,716 | -57.8% | Trimmed |
| NPCE Neuropace Inc. | $2.6M | 0.9% | 163,000 | +158.7% | Added |
| NVDA NVIDIA Corporation | $2.4M | 0.8% | 11,844 | -7.3% | Trimmed |
| ATRC AtriCure Inc. | $2.3M | 0.8% | 83,720 | 0% | Unchanged |
| AAPL Apple Inc. | $2.2M | 0.7% | 7,608 | -3.0% | Trimmed |
| EWTX Edgewise Therapeutics Inc. | $2.2M | 0.7% | 53,179 | 0% | Unchanged |
| LLY Eli Lilly and Company | $2.1M | 0.7% | 1,734 | +0.3% | Added |
Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $299M in share positions; options and bonds count in the 13F value but not here.
Biggest buys in Q2 2026
- Fidelity Covington Trust Added+$19.7M
- SIBN SI-BONE Inc. Added+$4.3M
- Apogee Therapeutics Inc Com New+$4.3M
- DUOT Duos Technologies Group Inc. New+$3.5M
- NPCE Neuropace Inc. Added+$1.6M
- Crinetics Pharmaceuticals Inc Com Added+$677K
- NEO NeoGenomics Inc. Added+$477K
- JPMorgan U.s. Tech Leaders ETF Added+$375K
- Oneok Inc New New+$239K
- SNDK Sandisk Corporation New+$227K
Biggest sells in Q2 2026
- Centessa Pharmaceuticals PLC Sold out-$9.4M
- iShares TR Trimmed-$5.3M
- ANAB AnaptysBio Inc. Trimmed-$3.7M
- iShares Msci Eafe Value ETF Trimmed-$1.6M
- PIPR Piper Sandler Companies Trimmed-$1.1M
- iShares TR Trimmed-$1.1M
- ORGO Organogenesis Holdings Inc. Trimmed-$708K
- Vanguard Index FDS Trimmed-$674K
- IUSV iShares Core S&P U.S. Value ETF Trimmed-$554K
- NVDA NVIDIA Corporation Trimmed-$186K
The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 45 new, 155 added, 91 trimmed, 38 sold out.
Sector mix
- Not listed with us60.7%
- Health Care18.9%
- n/a6.3%
- Technology5.6%
- Finance3.4%
- Industrials2.0%
- Consumer Discretionary1.8%
- Utilities0.4%
- Funds and other0.3%
- Telecommunications0.2%
- Consumer Staples0.1%
- Energy0.1%
13F value by quarter
More holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| TRV The Travelers Companies Inc. | $1.9M | 0.6% | 5,606 | +0.6% | Added |
| MSFT Microsoft Corporation | $1.7M | 0.6% | 4,684 | +4.0% | Added |
| HCAT Health Catalyst Inc | $1.7M | 0.6% | 871,082 | -3.5% | Trimmed |
| MMM 3M Company | $1.6M | 0.5% | 9,733 | -0.3% | Trimmed |
| iShares S&P Mid-Cap 400 Value ETF | $1.5M | 0.5% | 9,998 | +7.8% | Added |
| Crinetics Pharmaceuticals Inc Com | $1.4M | 0.5% | 38,595 | +88.3% | Added |
| iShares TR | $1.4M | 0.5% | 6,475 | +7.6% | Added |
| XENE Xenon Pharmaceuticals Inc. | $1.4M | 0.5% | 23,000 | 0% | Unchanged |
| iShares TR | $1.3M | 0.4% | 5,909 | +2.9% | Added |
| TSLA Tesla Inc. | $1.2M | 0.4% | 2,834 | 0% | Unchanged |
| XEL Xcel Energy Inc. | $1.1M | 0.4% | 13,138 | +0.5% | Added |
| iShares TR | $1.0M | 0.3% | 9,335 | +3.7% | Added |
| USB U.S. Bancorp | $1.0M | 0.3% | 16,643 | -1.9% | Trimmed |
| Vanguard Index FDS | $919K | 0.3% | 2,482 | +0.3% | Added |
| iShares TR | $914K | 0.3% | 9,230 | +2.0% | Added |
| HSBC HSBC Holdings plc. | $857K | 0.3% | 9,008 | 0% | Unchanged |
| SPY State Street SPDR S&P 500 ETF Trust Unit | $807K | 0.3% | 1,081 | -3.7% | Trimmed |
| GOOGL Alphabet Inc. | $784K | 0.3% | 2,193 | +8.2% | Added |
| PG Procter & Gamble Company | $764K | 0.3% | 5,210 | +1.4% | Added |
| AMZN Amazon.com Inc. | $711K | 0.2% | 2,983 | +5.2% | Added |
| SPDR Index SHS FDS | $695K | 0.2% | 13,425 | -10.5% | Trimmed |
| AUPH Aurinia Pharmaceuticals Inc | $597K | 0.2% | 35,196 | 0% | Unchanged |
| ECL Ecolab Inc. | $585K | 0.2% | 2,101 | +0.3% | Added |
| MO Altria Group Inc. | $568K | 0.2% | 7,889 | +1.6% | Added |
| JPMorgan U.s. Tech Leaders ETF | $567K | 0.2% | 5,085 | +194.6% | Added |
Showing the 50 largest of 559 share positions. The full filing on SEC EDGAR
Questions about HighMark Wealth Management LLC
- What does HighMark Wealth Management LLC own?
- In its Form 13F for Q2 2026, HighMark Wealth Management LLC reported 565 holdings worth $299M. The five largest were iShares TR, Fidelity Covington Trust, AXGN, iShares TR, iShares Msci Eafe Value ETF.
- What did HighMark Wealth Management LLC buy and sell in Q2 2026?
- HighMark Wealth Management LLC opened 45 new positions, added to 155, trimmed 91 and sold out of 38 compared with the quarter before.
- When did HighMark Wealth Management LLC file its latest 13F?
- Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 12, 2026.
From Form 13F filed by HighMark Wealth Management LLC (SEC CIK 0001802451) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds · Get this as JSON